A research team led by a University of Massachusetts Amherst scientist has made a significant genetic discovery that sheds light on the use of the drug caspofungin to treat a deadly fungal infection, Aspergillus fumigatus, which kills some 100,000 severely immunocompromised people each year.
Click here for original story, Genomic research aids in the effort to understand how to treat deadly fungal infections
Source: Phys.org